Boston deadheads its Lotus
Beset with problems from the off, the Lotus Edge aortic valve has finally been discontinued.
A lull in FDA Covid-19 test authorisations
Just as demand for coronavirus tests is peaking, the US regulator has a quiet week.
Qiagen enters the T-cell testing fray
At least two groups have posted early data on T-cell tests for Covid-19; now Qiagen has licensed tech to make its own.
First data hint at T-cell immunity to Covid-19
Oxford Immunotec’s test might be able to pinpoint those at low risk of reinfection.
Abbott’s Covid-19 antigen test shows promise in asymptomatics
Despite the FDA’s warning that antigen assays may only be used in patients with symptoms, one such test shows potential in the screening setting.
Can Omada do a Livongo?
Omada is better funded than its digital health rival Livongo, but can it achieve a similar valuation?
